Equinox Gold (CVE:EQX – Free Report) had its target price raised by Scotiabank from C$8.75 to C$9.00 in a research report released on Wednesday morning,BayStreet.CA reports.
A number of other analysts have also recently commented on EQX. Royal Bank of Canada lowered their price target on Equinox Gold from C$11.00 to C$10.00 in a research note on Monday, October 21st. CIBC upped their price target on Equinox Gold from C$8.80 to C$9.50 in a research note on Monday, December 2nd. Finally, Cormark upped their price target on Equinox Gold from C$9.00 to C$10.50 in a research note on Friday, January 10th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Equinox Gold has a consensus rating of “Moderate Buy” and a consensus price target of C$10.05.
Read Our Latest Analysis on Equinox Gold
Equinox Gold Stock Performance
Insider Buying and Selling
In other news, Senior Officer Sebastian D’amici sold 12,000 shares of the stock in a transaction that occurred on Thursday, January 9th. The stock was sold at an average price of C$8.75, for a total value of C$105,000.00. Also, Senior Officer Gordana Vicentijevic sold 7,000 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of C$7.67, for a total value of C$53,690.00.
About Equinox Gold
Equinox Gold Corp. engages in the acquisition, exploration, and development of mineral deposits. The company's principal properties include the Aurizona project covering a total land package of approximately 223,160 hectares located in Maranhão State, Brazil; and the Castle Mountain property situated in California, the United States.
Featured Articles
- Five stocks we like better than Equinox Gold
- ETF Screener: Uses and Step-by-Step Guide
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Election Stocks: How Elections Affect the Stock Market
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- What is the Australian Securities Exchange (ASX)
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Equinox Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equinox Gold and related companies with MarketBeat.com's FREE daily email newsletter.